CLINICAL_TRIALS
trial_result
· 2022-02-11
Clinical Trial Update: Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial [Phase 3]
Summary
A Phase 3 randomized controlled trial evaluating single-dose ciprofloxacin for treating childhood cholera has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Cholera | Phase 3 | Status: COMPLETED